RECURRENT VULVAR CANCER
Clinical trials for RECURRENT VULVAR CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT VULVAR CANCER trials appear
Sign up with your email to follow new studies for RECURRENT VULVAR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat vulvar cancer
Disease control Recruiting nowThis study is testing whether a combination of two existing cancer drugs, pembrolizumab and lenvatinib, can help control advanced vulvar cancer that has returned or spread and cannot be treated with surgery or radiation. It will enroll about 42 patients to see if the combination …
Matched conditions: RECURRENT VULVAR CANCER
Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Electric pulses and drug combo may spare women from mutilating vulvar cancer surgery
Disease control Recruiting nowThis study is testing a treatment called electrochemotherapy for women whose vulvar cancer has come back. The treatment combines a cancer drug with electric pulses to help the drug get into the tumor cells more effectively. The main goal is to shrink the tumors enough to avoid or…
Matched conditions: RECURRENT VULVAR CANCER
Phase: PHASE2 • Sponsor: Institute of Oncology Ljubljana • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC